AddLife AB (publ) (ALIF-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, AddLife AB (publ) (ALIF-B) has a cash flow conversion efficiency ratio of 0.018x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr104.00 Million ≈ $11.19 Million USD) by net assets (Skr5.66 Billion ≈ $609.54 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ALIF-B equity financing ratio to measure how much of total assets are equity-financed.
AddLife AB (publ) - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how AddLife AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check AddLife AB (publ) cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
AddLife AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of AddLife AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Skyward Specialty Insurance Group, Inc. Common Stock
NASDAQ:SKWD
|
0.042x |
|
Foran Energy Group Co Ltd
SHE:002911
|
-0.014x |
|
Alliance Financial Group Bhd
KLSE:2488
|
0.000x |
|
First National Financial Corp
TO:FN
|
-0.747x |
|
Central China Securities Co Ltd
SHG:601375
|
0.335x |
|
Bangchak Corporation Public Company Limited
BK:BCP
|
0.161x |
|
Formula Systems 1985 Ltd ADR
NASDAQ:FORTY
|
0.009x |
|
AvidXchange Holdings Inc
NASDAQ:AVDX
|
0.034x |
Annual Cash Flow Conversion Efficiency for AddLife AB (publ) (2012–2025)
The table below shows the annual cash flow conversion efficiency of AddLife AB (publ) from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see AddLife AB (publ) (ALIF-B) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr5.45 Billion ≈ $586.18 Million |
Skr1.39 Billion ≈ $149.80 Million |
0.256x | +23.90% |
| 2024-12-31 | Skr5.31 Billion ≈ $571.33 Million |
Skr1.09 Billion ≈ $117.84 Million |
0.206x | +32.34% |
| 2023-12-31 | Skr4.96 Billion ≈ $533.78 Million |
Skr773.00 Million ≈ $83.19 Million |
0.156x | -14.77% |
| 2022-12-31 | Skr4.97 Billion ≈ $534.96 Million |
Skr909.00 Million ≈ $97.82 Million |
0.183x | -22.33% |
| 2021-12-31 | Skr4.29 Billion ≈ $461.77 Million |
Skr1.01 Billion ≈ $108.71 Million |
0.235x | -53.16% |
| 2020-12-31 | Skr1.89 Billion ≈ $203.43 Million |
Skr950.10 Million ≈ $102.25 Million |
0.503x | +85.31% |
| 2019-12-31 | Skr1.48 Billion ≈ $158.86 Million |
Skr400.40 Million ≈ $43.09 Million |
0.271x | +42.37% |
| 2018-12-31 | Skr931.70 Million ≈ $100.27 Million |
Skr177.50 Million ≈ $19.10 Million |
0.191x | -31.49% |
| 2017-12-31 | Skr748.00 Million ≈ $80.50 Million |
Skr208.00 Million ≈ $22.38 Million |
0.278x | +50.00% |
| 2016-12-31 | Skr716.90 Million ≈ $77.15 Million |
Skr132.90 Million ≈ $14.30 Million |
0.185x | -45.41% |
| 2015-12-31 | Skr346.60 Million ≈ $37.30 Million |
Skr117.70 Million ≈ $12.67 Million |
0.340x | -25.74% |
| 2014-12-31 | Skr263.30 Million ≈ $28.34 Million |
Skr120.40 Million ≈ $12.96 Million |
0.457x | +35.58% |
| 2013-12-31 | Skr271.60 Million ≈ $29.23 Million |
Skr91.60 Million ≈ $9.86 Million |
0.337x | -16.59% |
| 2012-12-31 | Skr293.30 Million ≈ $31.56 Million |
Skr118.60 Million ≈ $12.76 Million |
0.404x | -- |
About AddLife AB (publ)
AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical resear… Read more